Journal of Clinical Oncology , 0732-183X
Journal
Publications
- 2017
- E-pub ahead of print
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
Gary Middleton, 27 Feb 2017, In: Journal of Clinical Oncology .Research output: Contribution to journal › Article › peer-review
Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials
20 Feb 2017, In: Journal of Clinical Oncology . 35, 6, p. 622-628 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Randomized prospective biomarker trial of ERCC1 for comparing platinum and nonplatinum therapy in advanced non-small-cell lung cancer: ERCC1 Trial (ET)
Gary Middleton, David Ferry & 3 others, , 1 Feb 2017, In: Journal of Clinical Oncology . 35, 4, p. 402-411 10 p.Research output: Contribution to journal › Article › peer-review
- 2016
- Published
Risk of Adverse Health and Social Outcomes Up to 50 Years After Wilms Tumor: The British Childhood Cancer Survivor Study
Raoul Reulen, Emma Lancashire & Michael Hawkins, 20 May 2016, In: Journal of Clinical Oncology . 34, 15, p. 1772-1779Research output: Contribution to journal › Article › peer-review
- 2015
- Published
Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with resected squamous cell carcinoma of the head and neck: a phase III, randomized, double-blind, placebo-controlled study
Hisham Mehanna & 5 others, , 10 Dec 2015, In: Journal of Clinical Oncology . 33, 35, p. 4202-4209Research output: Contribution to journal › Article › peer-review
- Published
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
Charles Craddock, 1 Oct 2015, In: Journal of Clinical Oncology . 33, 28, p. 3144-51 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Collaborative Research in Childhood Cancer Survivorship: The Current Landscape
Michael Hawkins, 20 Sep 2015, In: Journal of Clinical Oncology . 33, 27, p. 3055-64 10 p.Research output: Contribution to journal › Article › peer-review
- Published
Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also
Daniel Rea, 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
Rich Fox, 20 Feb 2015, Journal of Clinical Oncology , 33, 6, p. 550 558 p.Research output: Contribution to specialist publication › Article
- 2014
- Published
Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study
Daniel Rea, 20 Sep 2014, In: Journal of Clinical Oncology. 32, 27, p. 2951-2958Research output: Contribution to journal › Article › peer-review